mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |